Subretinal hemorrhage after photodynamic therapy for juxtapapillary retinal capillary hemangioma

Case Reports in Ophthalmology

Volumn 2, Issue 1, 2011, Pages 134-139

  Baba, Takayuki ^a   Kitahashi, Masayasu ^a   Kubota Taniai, Mariko ^a   Oshitari, Toshiyuki ^a   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intravitreal bevacizumab; Juxtapapillary retinal capillary hemangioma; Photodynamic therapy; Subretinal hemorrhage

Indexed keywords

BEVACIZUMAB; SULFUR HEXAFLUORIDE; VERTEPORFIN;

AGED; ARTICLE; BLURRED VISION; CAPILLARY HEMANGIOMA; CASE REPORT; CATARACT; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; JUXTAPAPILLARY RETINA CAPILLARY HEMANGIOMA; OPHTHALMOSCOPY; OPTIC NERVE INJURY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DISEASE; RETINA EXUDATE; RETINA HEMORRHAGE; RETINA TUMOR; SLIT LAMP; SUBFOVEAL FLUID; SUBRETINAL FLUID; SUBRETINAL HEMORRHAGE; TREATMENT RESPONSE; TUMOR VOLUME; VISUAL ACUITY;

EID: 79957585521     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000328384     Document Type: Article

References (11)

1. Gass JD, Braunstein R: Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head. Arch Ophthalmol 1980;98:1790-1797. (Pubitemid 10020999)
2. McCabe CM, Flynn HW Jr, Shields CL, Shields JA, Regillo CD, McDonald HR, Berrocal MH, Gass JD, Mieler WF: Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology 2000;107:2240-2248.
3. Singh AD, Nouri M, Shields CL, Shields JA, Perez N: Treatment of retinal capillary hemangioma. Ophthalmology 2002;109:1799-1806.
4. Golshevsky JR, O'Day J: Photodynamic therapy in the management of juxtapapillary capillary haemangiomas. Clin Experiment Ophthalmol 2005;33:509-512. (Pubitemid 44056409)
5. Sachdeva R, Dadgostar H, Kaiser PK, Sears JE, Singh AD: Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol 2010;88:e334-e340.
6. Dahr SS, Cusick M, Rodriguez-Coleman H, Srivastava SK, Thompson DJ, Linehan WM, Ferris FL 3rd, Chew EY: Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel- Lindau disease of the retina. Retina 2007;27:150-158.
7. Ziemssen F, Voelker M, Inhoffen W, Bartz-Schmidt KU, Gelisken F: Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye (Lond) 2007;21:1125-1126. (Pubitemid 47263771)
8. Mennel S, Meyer CH, Callizo J: Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma. Acta Ophthalmol 2010;88:610-613.
9. Reynolds SA, Shechtman D, Falco L: Complex juxtapapillary capillary hemangioma: A case report. Optometry 2008;79:512-517.
10. von Buelow M, Pape S, Hoerauf H: Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol Scand 2007;85:114-116. (Pubitemid 46140169)
11. Melmon KL, Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 1964;36:595-617.